Ingrid Øra

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. pmc Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome
    Sandra Jester
    Department of Pediatrics, Clinical Sciences, Lund University, Lund, Sweden
    Orphanet J Rare Dis 8:134. 2013
  2. pmc ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours
    Annica Wilzén
    Department of Clinical Genetics, Institution of Biomedicine, Box 413, S 405 30, Gothenburg University, Gothenburg, Sweden
    Mol Cancer 12:70. 2013
  3. pmc Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort study
    Anna Sällfors Holmqvist
    Pediatric Oncology and Hematology, Skane University Hospital, Clinical Sciences, Lund University, Lund, Sweden
    BMC Cancer 14:419. 2014
  4. pmc Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
    Fieke Lamers
    Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, Amsterdam, AZ 1105, The Netherlands
    BMC Cancer 12:285. 2012
  5. ncbi request reprint Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research
    Ingrid Øra
    Department of Pediatric Oncology and Hematology, Skane University Hospital, Lund University, Lund, Sweden
    Semin Cancer Biol 21:217-28. 2011

Collaborators

  • Anna Sällfors Holmqvist
  • Annica Wilzén
  • Sandra Jester
  • Rogier Versteeg
  • Fieke Lamers
  • Thomas Wiebe
  • Anna Lindgren
  • Lars Hjorth
  • Stanislaw Garwicz
  • Christian Moell
  • Albert N Bekassy
  • Daniel Dalevi
  • Katleen De Preter
  • Erik Kristiansson
  • Julia Larsson
  • Staffan Nilsson
  • Cecilia Krona
  • Dominik Turkiewicz
  • Jacek Toporski
  • Domniki Papadopoulou
  • Frida Abel
  • Raymond L Stallings
  • Baldur Sveinbjörnsson
  • Per Kogner
  • John Maris
  • Erik A Eklund
  • Jan Eric Mansson
  • Peter van Sluis
  • Jan Koster
  • Jan J Molenaar
  • Frank Speleman
  • Linda Schild
  • Ellen M Westerhout
  • Huib N Caron

Detail Information

Publications5

  1. pmc Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome
    Sandra Jester
    Department of Pediatrics, Clinical Sciences, Lund University, Lund, Sweden
    Orphanet J Rare Dis 8:134. 2013
    ..This is the first report on haploidentical SCT in patients with MPS VI. The primary objective was to assess the treatment safety and clinical and biochemical outcome...
  2. pmc ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours
    Annica Wilzén
    Department of Clinical Genetics, Institution of Biomedicine, Box 413, S 405 30, Gothenburg University, Gothenburg, Sweden
    Mol Cancer 12:70. 2013
    ..In the current study we characterized these different subgroups in more detail, with a specific focus on the fourth divergent tumour subgroup (r4)...
  3. pmc Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort study
    Anna Sällfors Holmqvist
    Pediatric Oncology and Hematology, Skane University Hospital, Clinical Sciences, Lund University, Lund, Sweden
    BMC Cancer 14:419. 2014
    ....
  4. pmc Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
    Fieke Lamers
    Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, Amsterdam, AZ 1105, The Netherlands
    BMC Cancer 12:285. 2012
    ..Neuroblastoma are pediatric tumors of the sympathetic nervous system with a poor prognosis. Apoptosis is often deregulated in cancer cells, but only a few defects in apoptotic routes have been identified in neuroblastoma...
  5. ncbi request reprint Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research
    Ingrid Øra
    Department of Pediatric Oncology and Hematology, Skane University Hospital, Lund University, Lund, Sweden
    Semin Cancer Biol 21:217-28. 2011
    ..This review describes the current efforts and trends in neuroblastoma research from a clinical perspective in order to highlight the urgent clinical problems we must address together with basic researchers...